Drug recall · June 7, 2017
ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable recall
Why: Lack of assurance of sterility: Product bags leaking at seam.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g, Total Approximate Volume 100 mL, Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0522-32
- Lots / codes
LOT # 20170510@12, Use By: 06-24-17
- Quantity
- 240 bags
- Company
- SCA Pharmaceuticals, Little Rock, AR
- Distribution
- Nationwide in the USA
- Initiated
- May 18, 2017 · Voluntary: Firm initiated
- Classified
- May 31, 2017
- Reported
- June 7, 2017
- Ended
- March 29, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefazolin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.